NIH-funded research P01 program project

Precision cardiovascular disease profiling in South Asian adults

Official title: Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)

Funded at Emory University · NIH-11617876 · Data updated 2026-11-12

This grant aims to improve how we predict and prevent heart disease in adults, using detailed measurements and real-time behavior data from a large South Asian cohort.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startMay 15, 2022
Project endFebruary 28, 2027
Funding year2026
Award (this year)$426,183
NIH project number3P01HL154996-05S1
Project IDNIH-11617876 on NIH RePORTER

Who could benefit from this research

Could help

Adults of South Asian descent (≥20 years) who are part of or similar to the CARRS cohort and have ongoing follow-up opportunities for ASCVD risk factors and related outcomes.

Less likely to help

Individuals not at elevated ASCVD risk or those not eligible for long-term follow-up may see limited direct benefit.

What this research studies

Precision-CARRS seeks to move from broad, late-stage risk thinking to personalized prediction for ASCVD and heart failure by studying genetic, environmental, behavioral, and molecular factors. The project builds on the NHLBI-supported CARRS cohort of over 21,000 South Asians aged 20 and older, with extensive follow-up and a large biorepository. Researchers will add deep clinical and subclinical heart disease phenotyping, regular protein and omics profiling, and real-time health behavior monitoring to extend follow-up by about five years. This could reveal how early-life factors and daily exposures shape disease risk and progression in a high-risk population. The study aims to generate insights that could guide earlier, more precise prevention and treatment approaches in ASCVD and HF.

Why it matters

Potential benefit: If successful, patients could receive more personalized prevention strategies and earlier interventions for ASCVD and heart failure.

How similar studies have gone: Previous cohorts with deep phenotyping and multi-omics have improved risk prediction and understanding of ASCVD pathways, supporting a promising path here.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Narayan, Kabayam M Venkat — Emory University
  • Study coordinator: Narayan, Kabayam M Venkat

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.